SIP
TGTX icon

Stoneridge Investment Partners’s TG Therapeutics TGTX Stock Holding History

Stoneridge Investment Partners’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-8,041
Closed -$215K – 128
2020
Q3 		$215K Buy
+8,041
New +$185K 0.14% 101
2018
Q2 		– Sell
-56,176
Closed -$798K – 179
2018
Q1 		$798K Sell
56,176
-15,822
-22% -$202K 0.13% 90
2017
Q4 		$590K Hold
71,998
– – 0.09% 111
2017
Q3 		$853K Sell
71,998
-32,934
-31% -$375K 0.13% 111
2017
Q2 		$1.05M Sell
104,932
-158,798
-60% -$1.78M 0.16% 111
2017
Q1 		$3.07M Sell
263,730
-25,614
-9% -$184K 0.41% 87
2016
Q4 		$1.34M Hold
289,344
– – 0.18% 150
2016
Q3 		$2.24M Sell
289,344
-6,138
-2% -$39.5K 0.32% 111
2016
Q2 		$1.79M Hold
295,482
– – 0.27% 119
2016
Q1 		$2.52M Sell
295,482
-37,094
-11% -$325K 0.37% 93
2015
Q4 		$3.97M Buy
332,576
+77,179
+30% +$975K 0.53% 56
2015
Q3 		$2.57M Sell
255,397
-1,938
-0.8% -$28.9K 0.36% 86
2015
Q2 		$4.27M Sell
257,335
-51,409
-17% -$814K 0.53% 48
2015
Q1 		$4.78M Buy
308,744
+78,219
+34% +$1.18M 0.56% 51
2014
Q4 		$3.65M Buy
230,525
+163,327
+243% +$2.13M 0.48% 72
2014
Q3 		$717K Sell
67,198
-57
-0.1% -$529 0.11% 169
2014
Q2 		$632K Sell
67,255
-2,050
-3% -$13.1K 0.09% 168
2014
Q1 		$478K Sell
69,305
-1,800
-3% -$10.7K 0.09% 125
2013
Q4 		$277K Buy
71,105
+38,963
+121% +$157K 0.05% 164
2013
Q3 		$162K Buy
+32,142
New +$197K 0.04% 195

Other funds holding TGTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Stoneridge Investment Partners's TGTX Position: Q4 2020 in Review

Stoneridge Investment Partners sold out of TG Therapeutics (TGTX) in Q4 2020, closing a stake of 8,041 shares — an estimated $215K sold.

Stoneridge Investment Partners first reported a position in TGTX in Q3 2013 and held it in 20 quarters. The position peaked at $4.78M in Q1 2015. 247 funds tracked by Wall St. Rank hold TGTX as of Q4 2020.

  • Stoneridge Investment Partners reported no remaining TG Therapeutics position as of Q4 2020 after selling out during the quarter.
  • Stoneridge Investment Partners sold 8,041 TG Therapeutics shares in Q4 2020, an estimated $215K.
  • Stoneridge Investment Partners first reported a position in TG Therapeutics in Q3 2013 and held it in 20 quarters.
  • Stoneridge Investment Partners's TG Therapeutics position peaked at $4.78M in Q1 2015.
  • 247 funds tracked by Wall St. Rank held TG Therapeutics as of Q4 2020.

Based on Stoneridge Investment Partners's 13F filing for Q4 2020, filed 2 Feb 2021.